News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
Presentation ACC 2021 Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction Presenter: Deepak L. Bhatt May 17, 2021
News Conference News ACC 2021 Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM L.A. McKeown May 16, 2021
News Conference News ACC 2021 Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes Todd Neale May 16, 2021
News Conference News ACC 2021 Even With Stent Cards, Patients Often Hazy on PCI Details Years Later Michael O'Riordan May 11, 2021